542 related articles for article (PubMed ID: 29912983)
1. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
[TBL] [Abstract][Full Text] [Related]
2. A PERIOD3 variable number tandem repeat polymorphism modulates melatonin treatment response in delayed sleep-wake phase disorder.
Magee M; Sletten TL; Murray JM; Gordon CJ; Lovato N; Bartlett DJ; Kennaway DJ; Lockley SW; Lack LC; Grunstein RR; Archer SN; Rajaratnam SMW;
J Pineal Res; 2020 Nov; 69(4):e12684. PubMed ID: 32682347
[TBL] [Abstract][Full Text] [Related]
3. Sleep regularity is associated with sleep-wake and circadian timing, and mediates daytime function in Delayed Sleep-Wake Phase Disorder.
Murray JM; Phillips AJK; Magee M; Sletten TL; Gordon C; Lovato N; Bei B; Bartlett DJ; Kennaway DJ; Lack LC; Grunstein RR; Lockley SW; Rajaratnam SMW;
Sleep Med; 2019 Jun; 58():93-101. PubMed ID: 31132578
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.
Grima NA; Rajaratnam SMW; Mansfield D; Sletten TL; Spitz G; Ponsford JL
BMC Med; 2018 Jan; 16(1):8. PubMed ID: 29347988
[TBL] [Abstract][Full Text] [Related]
5. Low dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings.
Swanson LM; Sibour T; DuBuc K; Conroy DA; Raglan GB; Lorang K; Zollars J; Hershner S; Arnedt JT; Burgess HJ
J Clin Sleep Med; 2024 Mar; ():. PubMed ID: 38445651
[TBL] [Abstract][Full Text] [Related]
6. Circadian tau differences and rhythm associations in delayed sleep-wake phase disorder and sighted non-24-hour sleep-wake rhythm disorder.
Micic G; Lovato N; Ferguson SA; Burgess HJ; Lack L
Sleep; 2021 Jan; 44(1):. PubMed ID: 32619243
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity of the circadian system to light in delayed sleep-wake phase disorder.
Watson LA; Phillips AJK; Hosken IT; McGlashan EM; Anderson C; Lack LC; Lockley SW; Rajaratnam SMW; Cain SW
J Physiol; 2018 Dec; 596(24):6249-6261. PubMed ID: 30281150
[TBL] [Abstract][Full Text] [Related]
8. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
[TBL] [Abstract][Full Text] [Related]
9. Circadian Melatonin and Temperature Taus in Delayed Sleep-wake Phase Disorder and Non-24-hour Sleep-wake Rhythm Disorder Patients: An Ultradian Constant Routine Study.
Micic G; Lovato N; Gradisar M; Burgess HJ; Ferguson SA; Lack L
J Biol Rhythms; 2016 Aug; 31(4):387-405. PubMed ID: 27312974
[TBL] [Abstract][Full Text] [Related]
10. Can the circadian phase be estimated from self-reported sleep timing in patients with Delayed Sleep Wake Phase Disorder to guide timing of chronobiologic treatment?
Lovato N; Micic G; Gradisar M; Ferguson SA; Burgess HJ; Kennaway DJ; Lack L
Chronobiol Int; 2016; 33(10):1376-1390. PubMed ID: 27611743
[TBL] [Abstract][Full Text] [Related]
11. Sleep and circadian variability in people with delayed sleep-wake phase disorder versus healthy controls.
Burgess HJ; Park M; Wyatt JK; Rizvydeen M; Fogg LF
Sleep Med; 2017 Jun; 34():33-39. PubMed ID: 28522096
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
13. Sleep and circadian instability in delayed sleep-wake phase disorder.
Watson LA; McGlashan EM; Hosken IT; Anderson C; Phillips AJK; Cain SW
J Clin Sleep Med; 2020 Sep; 16(9):1431-1436. PubMed ID: 32347206
[TBL] [Abstract][Full Text] [Related]
14. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective and objective sleepiness and cognitive function.
Wilhelmsen-Langeland A; Saxvig IW; Pallesen S; Nordhus IH; Vedaa Ø; Lundervold AJ; Bjorvatn B
J Biol Rhythms; 2013 Oct; 28(5):306-21. PubMed ID: 24132057
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
